Dept. of Molecular and Medical Genetics
Oregon Health & Science University
The Î³â isoform of fibrinogen is associated with cardiovascular disease (CVD) and may be useful for cardiovascular risk prediction. This isoform is produced through the incorporation of a splice variant of the fibrinogen Î³ chain into the molecule, and its levels vary between individuals. It has been proposed that Î³â fibrinogen may increase the risk of thrombosis through its interactions with thrombin, the major blood coagulation enzyme. In this dissertation, the role of electrostatic interactions in this binding was investigated using surface plasmon resonance technology. Our findings indicate that the binding of exosite II of thrombin to the Î³â chain is mediated by the ensemble of negatively-charged residues in the Î³â chain carboxyl terminus, and that no single charged residue is absolutely required. As CVD appears to be an inflammatory process, the relationship between Î³â fibrinogen and inflammation was explored in a cohort of subjects from the Periodontitis and Vascular Events (PAVE)
School of Medicine
Alexander, Kristine S., "Characterization of [gamma]' fibrinogen as a cardiovascular risk marker" (2012). Scholar Archive. 867.